Pharmaceutical Development and Regulation

Equity, Access and Economic Evaluation in Rare Diseases: The Impact of Orphan Drug Legislation on Health Policy and Patient Care
pp. 151-157(7)
Authors: Bosanquet N.; Domenighetti G.; Beresniak A.; Auray J-P.; Crivelli L.; Richard L.; Howard P.

Predictive Software for Drug Design and Development: Recent Progress and Future Developments
pp. 159-168(10)
Author: Jackson R.C.

Potential Expanded Use of Pharmacoeconomics and Outcomes Research in China
pp. 169-177(9)
Authors: Liu G.G.; Liu C.

Bioequivalence Behind the Scenes
pp. 179-189(11)
Author: Marzo A.

Monitoring of Biomedical License Agreements: A Practical Guide
pp. 191-203(13)
Authors: Keller G.H.; Ferguson S.M.; Pan P.

Determining Consumer Willingness to Pay, Risk Behavior and Preferences: For Regulation of Natural Health Products
pp. 205-213(9)
Authors: Norrie O.; Metge C.J.

Pharmaceutical Decisions, New Developments and Proposed Regulations: From the Food Drug Cosmetic Law Reporter
pp. 215-221(7)
Author: Limited A.I.